Privia Health Group Target Price

Analysts' average 12-month price target for Privia Health Group is $25.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.79

Average Target Price

$25.00

5.1% upside

2 analysts in the last 4 months

High: $26 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-26	BarclaysAndrew Mok	$24	0.9% upside
2026-04-08	Evercore ISI	$26	9.3% upside
2026-02-26	JefferiesJack Slevin	$32	34.5% upside
2026-02-26	Piper SandlerJessica Tassan	$36	51.3% upside
2026-01-09	RBC Capital	$31	30.3% upside
2026-01-06	Wolfe Research	$31	30.3% upside
2025-11-12	Canaccord Genuity	$34	42.9% upside
2025-10-09	Barclays	$22	7.5% downside
2025-08-29	JMP Securities	$30	26.1% upside
2025-04-15	Robert W. BairdMichael Ha	$26	9.3% upside
2025-02-28	JMP Securities	$29	21.9% upside
2025-02-28	Piper Sandler	$40	68.1% upside
2025-02-28	Canaccord Genuity	$30	26.1% upside
2025-01-10	NeedhamMatthew Shea	$25	5.1% upside
2024-08-26	Robert W. BairdMichael Ha	$24	0.9% upside
2024-08-08	Evercore ISIElizabeth Anderson	$22	7.5% downside
2024-05-20	BarclaysAndrew Mok	$19	20.1% downside
2024-05-15	Truist FinancialJailendra Singh	$24	0.9% upside
2022-12-08	UBS	$30	26.1% upside
2022-11-17	Canaccord GenuityCanaccord Canaccord	$43	80.7% upside
2022-11-11	Leerink Partners	$39	63.9% upside
2022-08-25	Canaccord Genuity	$50	110.2% upside
2022-08-12	Truist Financial	$48	101.8% upside
2022-08-12	Credit Suisse	$41	72.3% upside
2022-08-12	Cowen & Co.	$44	85% upside
2022-08-12	GuggenheimSandy Draper	$51	114.4% upside
2022-08-12	Leerink Partners	$46	93.4% upside
2022-07-25	Truist FinancialDavid MacDonald	$40	68.1% upside
2022-05-13	Canaccord Genuity	$29	21.9% upside
2022-04-28	BTIG	$35	47.1% upside

Privia Health Group (PRVA) FAQ

As of the most recent data, PRVA shows a target price of $25. Scroll down for historical charts and peer comparison views.

If Privia Health Group moved to the average analyst target of $25, shares would be roughly 5.1% higher than $23.79. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Privia Health Group's earnings trajectory.

Besides this target price page, Stockcircle has Privia Health Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $25) with ownership activity and broader fundamentals.

Privia Health Group's target price is $25; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.